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A commentary on
Effects of psilocybin on time perception and temporal control of behavior in humans
by Wittmann, M., Carter, O., Hasler, F., Cahn, B. R., Grimberg, U., Spring, P., et al. (2007).
J. Psychopharmacol. 21, 50–64. doi: 10.1177/0269881106065859
INTRODUCTION
WediscussWittmann et al. (2007) “Effects of Psilocybin on Time Perception and Temporal Control
of Behavior in Humans,” proposing that altered states of consciousness induced by pharmacological
treatments and neurological disorders can reveal much about the circuitry underlying time
perception in normal states of consciousness. Further research is needed to integrate these separate
research domains.
The brain integrates partial sensory input with internal representations to construct the
elaborate story we know as time (Hammond, 2012). Our ordinary experiences reveal the
complicated game the mind can play with perceived time: the day drags when we are bored,
yet slips through our fingers when distracted or amused. Despite varying phenomenological
experiences of time, the appropriate integration of physical time with functional behavior requires a
sufficiently accurate perception structured by the conceptual framework of past, present, and future
(Eagleman et al., 2005). Working memory, attention, and executive control support this integrated
construction (Fuchs, 2007; Marchetti, 2014). Effects on human time perception are observed when
these cognitive systems are modulated by pharmacological treatments or psychiatric disorders
(González-Maeso and Sealfon, 2009), suggesting the presence of a neurophysiological process that
is intrinsic to temporal information processing (Rammsayer, 2008).
PSILOCYBIN AND TEMPORAL PROCESSING IN NORMAL
SUBJECTS
Serotonergic hallucinogens generally slow the perceived flow of time (Shanon, 2003).
Pharmacological manipulations using psilocybin have shed light on mechanisms responsible for
this distorted time experience. Wittmann et al. (2007) investigated time estimation under the
influence of psilocybin. The study addressed the functional role of serotoninergic 5-HT2A receptors
in internal clock models (ICMs) in duration discrimination and temporal control of motor
performance. The study revealed a decreased ability to accurately produce intervals longer than
3 s and synchronize finger-tapping to auditory beats separated by more than 2 s. This suggests that
effects of psilocybin on temporal processing are specific to relatively long durations, attributable to
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memory, and decision-making components of the ICM
(Gibbon et al., 1984; Block and Zakay, 1996; Rammsayer,
2008; Allman and Meck, 2012), rather than to more basic
pacemaker/accumulator mechanisms (Wittmann et al., 2007).
Comparable results are observed inWackermann et al. (2008),
assessing psilocybin duration reproductions of intervals between
1.5 and 5 s. The analyses rely on the “dual klepsydra” model
(DKM), a contemporary alternative to the ICM. In the study,
the DKM model is applied to Wittmann et al. (2007) data as well
as new data. Results indicate temporal processing influenced by
psilocybin are dose-dependent (Wackermann et al., 2008).
Temporal processing of longer durations is impaired in people
with schizophrenia (Fuchs, 2005; Bonnot et al., 2011). However,
recent meta-analyses suggest that timing deficits in schizophrenia
generalize across sub- and supra-second intervals, as well as
across perceptual and motor tasks; and are independent from
more generalized cognitive impairments (Alústiza et al., 2016;
Ciullo et al., 2016). The employment of psychoactive substances
may be a useful approach to understanding temporal processing
in both the ordinary brain and that which is affected by
psychiatric disorders.
5-HT2A RECEPTORS AND TEMPORAL
PROCESSING IN SCHIZOPHRENIA
Psychopharmacological research suggests that drugs such as
psilocybin may serve as useful tools for understanding temporal
serotonergic signaling mechanisms underlying psychosis, due
to their capacity to cause distorted perception in normal
subjects (Rammsayer, 2008; González-Maeso and Sealfon, 2009).
Modulated 5-HT2A receptor agonists may induce clinical
symptoms of schizophrenia such as hallucinations, delusion,
psychomotor poverty, and distorted perception (Teixeira et al.,
2013), including distorted time perception (Allman and Meck,
2012). Pharmaceutical alterations of 5-HT2AR activation have
shown to assist NMDAR-dependent memory mechanisms
(Zhang and Stackman, 2015), and demonstrate that altered time
perception is a defining characteristic in schizophrenia due to
cognitive changes from NMDA receptor antagonists (Ciullo
et al., 2016). Additionally, dopamine-release manipulations cause
motor and cognitive defects seen in schizophrenia (Raote et al.,
2007), and impair duration discrimination in healthy subjects
(Wittmann, 2009). Likewise, schizophrenia is associated with
poor accumulation of signal durations derived from impairments
in sensory integration (Allman and Meck, 2012; Teixeira et al.,
2013). Sysoeva et al. (2010) found that genotypes characterized
by higher 5-HT transmission exemplify a higher “loss rate” of
duration representation, which may correlate to the very high
5-HT2A R occupancy in the prefrontal cortex of schizophrenic
patients (Zhang and Stackman, 2015).
Impairments in working memory, selective attention, and
executive control, as seen in schizophrenia, lead to distorted
sequencing and integration of past, present, and future into a
personal narrative. Carter et al. (2005) demonstrate a reduction in
attentional tracking abilities affected by psilocybin, and implicate
5-HT receptors in these processes through pretreatment of the
5-HT2A receptor antagonist ketanserin.
PROPOSAL FOR INTEGRATIVE RESEARCH
5-HT2A receptor activity is associated with time distortion
in both psychiatric disorders and hallucinogenic experiences.
Manipulating antagonists/agonists provides an approach
to utilizing psychoactive drugs as tools in research for
understanding time perception in the ordinary brain. It would
be fruitful to compare healthy subjects under the influence
of psilocybin with patients with acute schizophrenia, utilizing
a common paradigm as in Wittmann et al. (2007). However,
Wittmann et al. (2007) excludes significant moderating factors of
time estimation: attention and emotion (Droit-Volet and Meck,
2007). An fMRI test of acute treatment with psilocybin in healthy
volunteers found decreased amygdala reactivity during emotion
processing (Kraehenmann et al., 2015). Negative pictures led
to an overestimation of duration, indicating greater attention
allotted to emotional valence (Wittmann, 2009).
Neuroimaging techniques combined with psychophysical
tests of time perception (for a review see Grondin, 2010),
including manipulations to assess attentional and emotional
factors, will illuminate neural activity responsible for temporal
processing in schizophrenia and psychedelic perceptions.
Comparing performance and brain activities in these altered
states with those of untreated healthy subjects under the same
experimental conditions will elucidate mechanisms underlying
time perception.
CONCLUSION
Slowing of perceived time is induced by psilocybin and
schizophrenia; having a common basis in 5-HT2A receptor
activities. Commonalities across pharmacological treatments and
neurological disorders should be explored within a common
experimental paradigm to better understand neurochemical
processes mediating temporal processing in ordinary states.
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